middle.news
InhaleRx Advances Clinical Trials, Raises $857k, and Plans Strategic Rebrand
1:42pm on Thursday 29th of January, 2026 AEDT
•
Healthcare
Read Story
InhaleRx Advances Clinical Trials, Raises $857k, and Plans Strategic Rebrand
1:42pm on Thursday 29th of January, 2026 AEDT
Key Points
Raised $857,730 through Placement and Entitlement Offer to fund operations
Extended $12.6 million funding agreement to support SRX-25 through Phase 3 readiness
IRX-211 Phase 2 trial delayed but site budget issues now resolved
IRX-616a Phase 1 trial preparations underway with site activation planned for Q1
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
INHALERX (ASX:IRX)
OPEN ARTICLE